Last reviewed · How we verify
NCT06950021: CANOPIN
Safety & Performance of CANOpus PINtuition Surgical Marker Navigation
NA trial testing Magnetic seed in Breast Surgery in 35 participants. Not yet recruiting.
1 November 2025
Quick facts
| Lead sponsor | Sirius Medical Systems B.V. |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 35 |
| Start date | 1 July 2025 |
| Primary completion | 1 November 2025 |
| Estimated completion | 1 February 2026 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Magnetic seed
Conditions studied
- Breast Surgery — all drugs for Breast Surgery →
- Lymph Node Excision — all drugs for Lymph Node Excision →
Sponsor
Sirius Medical Systems B.V.
Who can join
18 and older, any sex, with Breast Surgery or Lymph Node Excision. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to evaluate the safety and performance of the Canopus Marker in adult breast cancer patients who are scheduled for breast-conserving surgery. The main questions it aims to answer are: 1. Can the Canopus Marker be safely and effectively used to mark tissue for surgical removal? 2. What is the satisfaction level of radiologists, surgeons, and patients with the use of the Canopus Marker? Participants will: * Have the Canopus Marker implanted into the tumor or nearby tissue using ultrasound guidance. * Undergo surgery where the Canopus Marker will help guide the surgeon to the tumor, and the marker will be removed along with the tumor. This surgery is performed using an FDA cleared and CE-marked detection device (Sirius Pintuition Detector). * Attend a follow-up visit two weeks after surgery to assess any adverse events and overall satisfaction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06950021
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Surgery
Currently open trials in the same condition.
- NCT07154771 — Development and Usability Evaluation of an Arm Circumference Measurement Tool For Patients Undergoing Breast Surgery · NA · active not recruiting
- NCT07321145 — A Retrospective Analysis of Robot-Assisted Versus Endoscopic Breast-Conserving Surgery for Breast Cancer · NA · recruiting
- NCT07283120 — The Impact of Breast Surgery on Patients' Quality of Life · recruiting
- NCT06947642 — Ultrasound-guided Pectoral Nerve Blocks, Thoracic Erector Spinae Plane Block and Serratus Anterior Plane Block for Breas · NA · recruiting
- NCT07502846 — Superficial vs Deep Serratus Anterior Plane Block for Analgesia After Mammoplasty · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06950021 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sirius Medical Systems B.V.
- Last refreshed: 29 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06950021.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing